The Parliament of Georgia approved the vaccination plan in the second reading.

The change aims at effective implementation and management of the COVID-19 distribution, namely the special article is introduced to the law determining the parties responsible for the possible damage entailed by the pharmaceutical product (vaccine or medicine).

The bill imposes the responsibility to the state for the possible damage resulted from the use of the pharmaceutical product, authorized or pre-qualified by WHO or WHO-recognized regulatory bodies, imported for vaccination against COVID-19, other than the events when the responsibility for the damage is imposed to the importer, medical personnel, medical institution, or manufacturer pursuant to the contract concluded with the manufacturer.